Business Context and Reporting Period
This Form 8-K is a current report filed by Fluidigm Corporation (noted as Standard BioTools Inc. in metadata) on November 3, 2016. The filing serves to announce the company's financial results for the third quarter ended September 30, 2016. The detailed financial data is contained within the press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover document and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being reported in the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms that results for the third quarter of 2016 were issued.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. The filing explicitly states that the information in Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or incorporated by reference unless expressly set forth by specific reference.
Investor Verification Checklist
- Verify the specific revenue and net income figures for Q3 2016 by reviewing the attached press release (Exhibit 99.1).
- Confirm the company's current legal name, as the metadata lists "Standard BioTools Inc." while the filing header lists "Fluidigm Corporation."
- Review the full press release for any forward-looking statements or guidance not summarized in this 8-K cover sheet.
- Check subsequent filings to see if the press release was later incorporated by reference into other SEC documents.